Inhibition by levetiracetam of a non-GABA(A) receptor-associated epileptiform effect of bicuculline in rat hippocampus

British Journal of Pharmacology

Volumn 122, Issue 6, 1997, Pages 1146-1150

  Margineanu, Doru Georg ^a   Wülfert, Ernst ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Bicuculline; Epilepsy; Extracellular recordings; Flunarizine; Gabazine (SR 95531); Hippocampal CA3; Levetiracetam (ucb LO59)

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; BICUCULLINE; BICUCULLINE METHIODIDE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; FLUNARIZINE; NIFEDIPINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTRIC POTENTIAL; EPILEPSY; EPILEPTIC DISCHARGE; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICONVULSANTS; BICUCULLINE; CONVULSANTS; FLUNARIZINE; GABA ANTAGONISTS; HIPPOCAMPUS; MALE; PIRACETAM; PYRIDAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SEIZURES;

EID: 0030734833     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701476     Document Type: Article

References (29)

1. AICARDI, G. & SCHWARTZKROIN, P.A. (1990). Suppression of epileptiform burst discharges in CA3 neurons of rat hippocampal slices by the organic calcium channel blocker, verapamil. Exp. Brain Res., 81, 288-296.
2. AKAIKE, N., KOSTYUK, P.G. & OSIPCHUK, Y.V. (1989). Dihydropyridine-sensitive low-threshold calcium channels in isolated rat hypothalamic neurons. J. Physiol., 412, 181-195.
3. ANDERSEN, A. (1975). Organization of hippocampal neurons and their interconnections. In The Hippocampus, Vol. 1. ed. Isaacson, R.L. & Pribram, K.H. pp. 155-175. New York: Plenum.
4. BIRNSTIEL, S., WÜLFERT, E. & BECK, S.G. (1997). Levetiracetam (L059) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol. (in press).
5. DE SARRO, G.B., MELDRUM, B.S. & NISTICÓ, G. (1988). Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br. J. Pharmacol., 93, 247-256.
6. GOWER, A., NOYER, M., VERLOES, R., GOBERT, J. & WÜLFERT, E. (1992). ucb L059, a novel anti-convulsant drug: pharmacological profile in animals. Eur. J. Pharmacol., 222, 193-203.
7. GOWER, A., HIRSCH, E., BOEHRER, A., NOYER, M. & MARESCAUX, C. (1995). Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res., 22, 207-213.
8. HEYER, E.J., NOWAK, L.M. & MACDONALD, R.L. (1982). Membrane depolarization and prolongation of calcium-dependent action potentials of mouse neurons in cell culture by two convulsants: bicuculline and penicillin. Brain Res., 232, 41-56.
9. 2+ channel blocker and antioxidant, reduces neuronal ischemic injuries. Eur. J. Pharmacol., 257, 203-210.
10. JOHNSTON, D., FISHER, R. & GRAY, R. (1992). Voltage-gated calcium channels in adult hippocampal neurons. In Ionic Channels, Vol. 3. ed. Narahashi, T. pp. 39-62. New York: Plenum Press.
11. JOY, R.M. & ALBERTSON, T.E. (1992). In vivo assessment of the importance of GABA in convulsant and anticonvulsant drug action. Epilepsy Res., Suppl. 8, 63-75.
12. LÖSCHER, W. & HÖNACK, D. (1993). Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur. J. Pharmacol., 232, 147-148.
13. MACDONALD, R.L. & KELLY, K.M. (1995). Antiepileptic drug mechanisms of action. Epilepsia, 36, Suppl. 2, S2-12.
14. MACK, C.M. & GILBERT, M.E. (1992). An examination of the anticonvulsant properties of voltage-sensitive calcium channel inhibitors in amygdala kindled seizures. Psychopharmacology, 106, 365-369.
15. MARGINEANU, D.G. & WÜLFERT, E. (1995a). ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo. Eur. J. Pharmacol., 286, 321-325.
16. MARGINEANU, D.G. & WÜLFERT, E. (1995b). ucb L059, a novel anticonvulsant, reduces bicuculline-induced neuronal hyperexcitability, possibly through Ca-dependent mechanisms. Pharmacol. Res., 31S, 347.
17. MARGINEANU, D.G. & WÜLFERT, E. (1995c). Input-output dependence reveals the components of GABAergic modulation in rat hippocampal CA3 in vivo. Arch. Physiol. Biochem., 103, 115-121.
18. MUBHOFF, U., MADEJA, M., BLOMS-FUNKE, P. & SPECKMANN, E.-J. (1994). Effects of the epileptogenic agent bicuculline methiodide on membrane currents induced by N-methyl-D-aspartate and kainate (oocyte; Xenopus laevis). Brain Res., 639, 135-138.
19. OLSEN, R.W., BAN, M., MILLER, T. & JOHNSTON, G.A.R. (1975). Chemical instability of the GABA antagonist bicuculline under physiological conditions. Brain Res., 98, 383-387.
20. POPOLI, P., PÈZZOLA, A. & SCOTTI DE CAROLIS, A. (1990). Possible involvement of the adenosinergic system in flunarizine anticonvulsant activity in rats. Arch. Int. Pharmacodyn., 306, 45-56.
21. SCHARFMAN, H.E. (1994). Synchronization of area CA3 hippocampal pyramidal cells and non-granule cells of the dentate gyrus in bicuculline-treated rat hippocampal slices. Neuroscience, 59, 245-257.
22. SCHWARTZKROIN, P.A. & PRINCE, D.A. (1978). Cellular and field potential properties of epileptogenic hippocampal slices. Brain Res., 147, 117-130.
23. SILLS, G.J., LEACH, J.P., FRASER, C.M., FORREST, G., PATSALOS, P.N. & BRODIE, M.J. (1997). Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain. Eur. J. Pharmacol., 325, 35-40.
24. STEWARD, O., TOMASULO, R. & LEVY, W.B. (1990). Blockade of inhibition in a pathway with dual excitatory and inhibitory action unmasks a capability for LTP that is otherwise not expressed. Brain Res., 516, 292-300.
25. STRAUB, H., SPECKMANN, E.-J., BINGMANN, D. & WALDEN, J. (1990). Paroxysmal depolarization shifts induced by bicuculline in CA3 neurons of hippocampal slices: suppression by the organic calcium antagonist verapamil. Neurosci. Lett., 111, 99-101.
26. 2+ in neocortical tissue of epileptic and primary non-epileptic patients. Brain Res., 733, 307-311.
27. WANG, R., KARPINSKI, E., WU, L. & PANG, P.K.T. (1990). Flunarizine selectively blocks transient calcium channel currents in N1E-115 cells. J. Pharmacol. Exp. Ther., 254, 1006-1011.
28. A antagonists. Trends Pharmacol. Sci., 7, 421-424.
29. WÜLFERT, E. & MARGINEANU, D.G. (1996). Effects of in situ manipulation of nitric oxide on rat hippocampal CA3 neurone excitability. NeuroReport, 7, 2737-2742.